NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹339 Cr | ₹278 Cr | ₹318 Cr | ₹258 Cr | ₹152 Cr |
What is the latest Revenue of NGL FINECHEM ?
Year | Revenue |
---|---|
Mar2024 | ₹339 Cr |
Mar2023 | ₹278 Cr |
Mar2022 | ₹318 Cr |
Mar2021 | ₹258 Cr |
Mar2020 | ₹152 Cr |
How is Revenue of NGL FINECHEM Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹339 Cr | 21.79 | |
Mar2023 | ₹278 Cr | -12.42 | |
Mar2022 | ₹318 Cr | 23.08 | |
Mar2021 | ₹258 Cr | 70.07 | |
Mar2020 | ₹152 Cr | - |
Compare Revenue of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹822.1 Cr | 8.7% | 24.4% | -45.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 8.7% |
24.4% |
-45.3% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses